232 related articles for article (PubMed ID: 31832084)
1. Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria.
Iskandar K; Sartelli M; Tabbal M; Ansaloni L; Baiocchi GL; Catena F; Coccolini F; Haque M; Labricciosa FM; Moghabghab A; Pagani L; Hanna PA; Roques C; Salameh P; Molinier L
World J Emerg Surg; 2019; 14():50. PubMed ID: 31832084
[TBL] [Abstract][Full Text] [Related]
2. Prevention and control of surgical site infections: review of the Basel Cohort Study.
Junker T; Mujagic E; Hoffmann H; Rosenthal R; Misteli H; Zwahlen M; Oertli D; Tschudin-Sutter S; Widmer AF; Marti WR; Weber WP
Swiss Med Wkly; 2012; 142():w13616. PubMed ID: 22949137
[TBL] [Abstract][Full Text] [Related]
3. Diminishing surgical site infections in Australia: time trends in infection rates, pathogens and antimicrobial resistance using a comprehensive Victorian surveillance program, 2002-2013.
Worth LJ; Bull AL; Spelman T; Brett J; Richards MJ
Infect Control Hosp Epidemiol; 2015 Apr; 36(4):409-16. PubMed ID: 25782895
[TBL] [Abstract][Full Text] [Related]
4. The economic benefits of surgical site infection prevention in adults: a systematic review.
McFarland A; Reilly J; Manoukian S; Mason H
J Hosp Infect; 2020 Sep; 106(1):76-101. PubMed ID: 32417433
[TBL] [Abstract][Full Text] [Related]
5. Reducing adult cardiac surgical site infections and the economic impact of using multidisciplinary collaboration.
Chiwera L; Wigglesworth N; McCoskery C; Lucchese G; Newsholme W
J Hosp Infect; 2018 Dec; 100(4):428-436. PubMed ID: 29604297
[TBL] [Abstract][Full Text] [Related]
6. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries.
Badia JM; Casey AL; Petrosillo N; Hudson PM; Mitchell SA; Crosby C
J Hosp Infect; 2017 May; 96(1):1-15. PubMed ID: 28410761
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of surgical site infections at a tertiary care hospital in Greece: incidence, risk factors, microbiology, and impact.
Roumbelaki M; Kritsotakis EI; Tsioutis C; Tzilepi P; Gikas A
Am J Infect Control; 2008 Dec; 36(10):732-8. PubMed ID: 18834729
[TBL] [Abstract][Full Text] [Related]
8. High contribution and impact of resistant gram negative pathogens causing surgical site infections at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
El-Saed A; Balkhy HH; Alshamrani MM; Aljohani S; Alsaedi A; Al Nasser W; El Gammal A; Almohrij SA; Alyousef Z; Almunif S; Alzahrani M
BMC Infect Dis; 2020 Apr; 20(1):275. PubMed ID: 32264843
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.
Cranny G; Elliott R; Weatherly H; Chambers D; Hawkins N; Myers L; Sculpher M; Eastwood A
Health Technol Assess; 2008 Jan; 12(1):iii-iv, xi-xii, 1-147. PubMed ID: 18093447
[TBL] [Abstract][Full Text] [Related]
10. Burden of Surgical Site Infections Associated with Arthroplasty and the Contribution of Staphylococcus aureus.
Patel H; Khoury H; Girgenti D; Welner S; Yu H
Surg Infect (Larchmt); 2016 Feb; 17(1):78-88. PubMed ID: 26407172
[TBL] [Abstract][Full Text] [Related]
11. Global geographic trends in antimicrobial resistance: the role of international travel.
Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
[TBL] [Abstract][Full Text] [Related]
12. Measuring and mapping the global burden of antimicrobial resistance.
Hay SI; Rao PC; Dolecek C; Day NPJ; Stergachis A; Lopez AD; Murray CJL
BMC Med; 2018 Jun; 16(1):78. PubMed ID: 29860943
[TBL] [Abstract][Full Text] [Related]
13. Surgical site infection - a European perspective of incidence and economic burden.
Leaper DJ; van Goor H; Reilly J; Petrosillo N; Geiss HK; Torres AJ; Berger A
Int Wound J; 2004 Dec; 1(4):247-73. PubMed ID: 16722874
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections.
Dohmen PM
J Hosp Infect; 2008 Nov; 70 Suppl 2():15-20. PubMed ID: 19022117
[TBL] [Abstract][Full Text] [Related]
15. Effective prevention of surgical site infection using a Centers for Disease Control and Prevention guideline-based antimicrobial prophylaxis in lumbar spine surgery.
Kanayama M; Hashimoto T; Shigenobu K; Oha F; Togawa D
J Neurosurg Spine; 2007 Apr; 6(4):327-9. PubMed ID: 17436921
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections.
Whittle E; Yonkus JA; Jeraldo P; Alva-Ruiz R; Nelson H; Kendrick ML; Grys TE; Patel R; Truty MJ; Chia N
mSphere; 2022 Feb; 7(1):e0096421. PubMed ID: 35171692
[TBL] [Abstract][Full Text] [Related]
17. Incidence, microbiological profile of nosocomial infections, and their antibiotic resistance patterns in a high volume Cardiac Surgical Intensive Care Unit.
Sahu MK; Siddharth B; Choudhury A; Vishnubhatla S; Singh SP; Menon R; Kapoor PM; Talwar S; Choudhary S; Airan B
Ann Card Anaesth; 2016; 19(2):281-7. PubMed ID: 27052070
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.
Gurusamy KS; Koti R; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Aug; (8):CD010268. PubMed ID: 23959704
[TBL] [Abstract][Full Text] [Related]
19. Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases.
Abdul-Jabbar A; Berven SH; Hu SS; Chou D; Mummaneni PV; Takemoto S; Ames C; Deviren V; Tay B; Weinstein P; Burch S; Liu C
Spine (Phila Pa 1976); 2013 Oct; 38(22):E1425-31. PubMed ID: 23873240
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
